Stocks · Health care · Biological Products, (No Diagnostic Substances)

REPLIGEN CORP

RGEN Clue Score51

United States Fiscal year ends December CIK 0000730272 Results filed 27 Oct 2026

Add to watchlist

What the insiders did Net selling

Bought (120 mo)

$1.19M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$176.25M

$9.07M on a plan · $108.44M straight out of an exercise

Sold at will

$58.74M

170 of 346 sales

Net

−$175.07M

−$57.56M against sales at will